A Pilot Study of Ipilumimab and Radiation in Poor Prognosis Melanoma

Clinical trial NCT01996202 · COMPLETED

Trial details

NCT number: NCT01996202
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

High Risk Melanoma

Start date: 2013-11-01
Primary completion: 2018-09-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.